Literature DB >> 20031764

Clopidogrel for the hot patient.

Matthew L Bilodeau, Daniel I Simon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20031764      PMCID： PMC4086861          DOI： 10.1161/CIRCINTERVENTIONS.109.921577

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN： 1941-7640            Impact factor:   6.546


× No keyword cloud information.
  21 in total

1.  Inflammation and thrombosis: the clot thickens.

Authors:  P Libby; D I Simon
Journal:  Circulation       Date:  2001-04-03       Impact factor: 29.690

2.  Impact of clopidogrel on suppression of circulating levels of soluble CD40 ligand in patients with unstable angina undergoing coronary stenting.

Authors:  Hon-Kan Yip; Li-Teh Chang; Cheuk-Kwan Sun; Cheng-Hsu Yang; Wei-Chin Hung; Cheng-I Cheng; Sarah Chua; Kuo-Ho Yeh; Chiung-Jen Wu; Morgan Fu
Journal:  Am J Cardiol       Date:  2005-11-17       Impact factor: 2.778

3.  CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells.

Authors:  V Henn; J R Slupsky; M Gräfe; I Anagnostopoulos; R Förster; G Müller-Berghaus; R A Kroczek
Journal:  Nature       Date:  1998-02-05       Impact factor: 49.962

4.  Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis.

Authors:  F Mach; U Schönbeck; G K Sukhova; T Bourcier; J Y Bonnefoy; J S Pober; P Libby
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

5.  Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture?

Authors:  U Schönbeck; F Mach; G K Sukhova; C Murphy; J Y Bonnefoy; R P Fabunmi; P Libby
Journal:  Circ Res       Date:  1997-09       Impact factor: 17.367

6.  Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects.

Authors:  Thomas Heitzer; Volker Rudolph; Edzard Schwedhelm; Manuela Karstens; Karsten Sydow; Michelle Ortak; Peter Tschentscher; Thomas Meinertz; Rainer Böger; Stephan Baldus
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-05-04       Impact factor: 8.311

7.  CD40L stabilizes arterial thrombi by a beta3 integrin--dependent mechanism.

Authors:  Patrick André; K S Srinivasa Prasad; Cécile V Denis; Ming He; Jessie M Papalia; Richard O Hynes; David R Phillips; Denisa D Wagner
Journal:  Nat Med       Date:  2002-03       Impact factor: 53.440

8.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.

Authors:  P M Ridker; M Cushman; M J Stampfer; R P Tracy; C H Hennekens
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

9.  Reduction of atherosclerosis in mice by inhibition of CD40 signalling.

Authors:  F Mach; U Schönbeck; G K Sukhova; E Atkinson; P Libby
Journal:  Nature       Date:  1998-07-09       Impact factor: 49.962

10.  A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation.

Authors:  Steffen Massberg; Korbinian Brand; Sabine Grüner; Sharon Page; Elke Müller; Iris Müller; Wolfgang Bergmeier; Thomas Richter; Michael Lorenz; Ildiko Konrad; Bernhard Nieswandt; Meinrad Gawaz
Journal:  J Exp Med       Date:  2002-10-07       Impact factor: 14.307
View more
  1 in total

Review 1.  Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment?

Authors:  Guilherme R de Jesús; Gustavo Rodrigues; Nilson R de Jesús; Roger A Levy
Journal:  Curr Rheumatol Rep       Date:  2014-02       Impact factor: 4.592
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.